Viewing Study NCT00704704

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:15 PM
Ignite Modification Date: 2026-02-21 @ 1:02 PM
Study NCT ID: NCT00704704
Status: UNKNOWN
Last Update Posted: 2008-06-25
First Post: 2008-06-23
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety and Efficacy of Azacitidine, and Thalidomide in Higher Risk MDS (Myelodysplastic Syndrome)
Sponsor: Tel-Aviv Sourasky Medical Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myelodysplastic Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None high risk MDS View
None IPSS View
None 5-AZA-Cytidine View
None Thalidomide View
None response rate View
None cytogenetic response View
None QOL questionaries View
None INT-2 or High risk MDS View